Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract

BMC Infectious Diseases

Volumn 18, Issue 1, 2018, Pages

  Bidossi, Alessandro ^a   De Grandi, Roberta ^a   Toscano, Marco ^b   Bottagisio, Marta ^a   De Vecchi, Elena ^a   Gelardi, Matteo ^c   Drago, Lorenzo ^a,b  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Biofilm; Probiotics; Respiratory tract infections; Streptococcus oralis; Streptococcus salivarius

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; BIOFILM; CELL FREE SYSTEM; COCULTURE; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; MORAXELLA CATARRHALIS; NONHUMAN; PH; PROPIONIBACTERIUM ACNES; SPECIES DIFFERENCE; SPECTROPHOTOMETRY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS; CHILD; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTRANASAL DRUG ADMINISTRATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MICROFLORA; NOSE; ORGANISMAL INTERACTION; PATHOLOGY; PHARYNX; PHYSIOLOGY; PILOT STUDY; RESPIRATORY TRACT INFECTION; TRACHEA;

ADMINISTRATION, INTRANASAL; BIOFILMS; CHILD; HUMANS; MICROBIAL INTERACTIONS; MICROBIAL SENSITIVITY TESTS; MICROBIOTA; NOSE; PHARYNX; PILOT PROJECTS; PROBIOTICS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SALIVARIUS; TRACHEA;

EID: 85058502511     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-018-3576-9     Document Type: Article

References (49)

1. Morris DP. Bacterial biofilm in upper respiratory tract infections. Curr Infect Dis Rep. 2007;9:186-92.
2. Nazzari E, Torretta S, Pignataro L, Marchisio P, Esposito S. Role of biofilm in children with recurrent upper respiratory tract infections. Eur J Clin Microbiol Infect Dis. 2015;34:421-9. https://doi.org/10.1007/s10096-014-2261-1.
3. Danielsen KA, Eskeland O, Fridrich-Aas K, Orszagh VC, Bachmann-Harildstad G, Burum-Auensen E. Bacterial biofilms in patients with chronic rhinosinusitis: a confocal scanning laser microscopy study. Rhinology. 2014;52:150-5. https://doi.org/10.3109/00016489.2015.1092169.
4. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95-108. https://doi.org/10.1038/nrmicro821.
5. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11:1034-43. https://doi.org/10.1038/nrmicro821.
6. Yaguchi T, Dwidar M, Byun CK, Leung B, Lee S, Cho YK, et al. Aqueous two-phase system-derived biofilms for bacterial interaction studies. Biomacromolecules. 2012;13:2655-61. https://doi.org/10.1021/bm300500y.
7. Wang Z, Xiang Q, Yang T, Li L, Yang J, Li H, et al. Autoinducer-2 of Streptococcus mitis as a target molecule to inhibit pathogenic multi-species biofilm formation in vitro and in an endotracheal intubation rat model. Front Microbiol. 2016;7:e88. https://doi.org/10.3389/fmicb.2016.00088.
8. Goers L, Freemont P, Polizzi KM. Co-culture systems and technologies: taking synthetic biology to the next level. J R Soc Interface. 2014;11. https://doi.org/10.1098/rsif.2014.0065.
9. Bernstein JM, Sagahtaheri-Altaie S, Dryja DM, Wactawski-Wende J. Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-otitis-prone children. Acta Otorhinolaryngol. 1994;48:1-9.
10. Fujimori I, Hisamatsu K, Kikushima K, Goto R, Murakami Y, Yamada T. The nasopharyngeal bacterial flora in children with otitis media with effusion. Eur Arch Otorhinolaryngol. 1996;253:260-3.
11. FAO/WHO Expert Consultation. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, 2001.
12. Carlsson J, Grahnen H, Jonsson G, Wikner S. Early establishment of Streptococcus salivarius in the mouth of infants. J Dent Res. 1970;49:415-8.
13. Kazor CE, Mitchell PM, Lee AM, Stokes LN, Loesche WJ, Dewhirst FE, et al. Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol. 2003;41:558-63.
14. Sidjabat HE. Grahn Håkansson E, and Cervin ADraft genome sequence of the oral commensal Streptococcus oralis 89a with interference activity against respiratory pathogens. Genome Announc. 2016;4:e01546. https://doi.org/10.1128/genomeA.01546-15.
15. Santagati M, Scillato M, Stefani S. Genetic organization of Streptococcus salivarius 24SMBc blp-like bacteriocin locus. Front Biosci (Schol Ed). 2018;1(10):238-47.
16. Jimenez JC, Federle MJ. Quorum sensing in group A Streptococcus. Front Cell Infect Microbiol. 2014;12(4):127. https://doi.org/10.3389/fcimb.2014.00127.
17. Fiedler T, Riani C, Koczan D, Standar K, Kreikemeyer B, Podbielski A. Protective mechanisms of respiratory tract streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection. Appl Environ Microbiol. 2013;79:1265-76. https://doi.org/10.1128/AEM.03350-12.
18. Li J, Helmerhorst EJ, Leone CW, Troxler RF, Yaskell T, Haffajee AD, et al. Identification of early microbial colonizers in human dental biofilm. J Appl Microbiol. 2004;97:1311-8. https://doi.org/10.1111/j.1365-2672.2004.02420.x.
19. Roos K, Håkansson EG, Holm S. Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo-controlled trial. BMJ. 2001;322:210-2.
20. Skovbjerg S, Roos K, Holm SE, Grahn Håkansson E, Nowrouzian F, Ivarsson M, et al. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child. 2009;94:92-8. https://doi.org/10.1136/adc.2008.137414.
21. Santagati M, Scillato M, Patanè F, Aiello C, Stefani S. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol. 2012;65:23-31. https://doi.org/10.1111/j.1574-695X.2012.00928.x.
22. Santagati M, Scillato M, Muscaridola N, Metoldo V, La Mantia I, Stefani S. Colonization, safety, and tolerability study of the Streptococcus salivarius 24SMBc nasal spray for its application in upper respiratory tract infections. Eur J Clin Microbiol Infect Dis. 2015;34:2075-80. https://doi.org/10.1007/s10096-015-2454-2.
23. Marchisio P, Santagati M, Scillato M, Baggi E, Fattizzo M, Rosazza C, et al. Streptococcus salivarius 24SMB administered by nasal spray for the prevention of acute otitis media in otitis-prone children. Eur J Clin Microbiol Infect Dis. 2015;34:2377-83. https://doi.org/10.1007/s10096-015-2491-x.
24. Drago L, Vassena C, Saibene AM, Del Fabbro M, Felisati G. A case of coinfection in a chronic maxillary sinusitis of odontogenic origin: identification of Dialister pneumosintes. J Endod. 2013;39:1084-47. https://doi.org/10.1016/j.joen.2013.04.025.
25. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22:996-1006.
26. Standar K, Kreikemeyer B, Redanz S, Münter WL, Laue M, Podbielski A. Setup of an in vitro test system for basic studies on biofilm behavior of mixed-species cultures with dental and periodontal pathogens. PLoS One. 2010;5:e13135. https://doi.org/10.1371/journal.pone.0013135.
27. Singh VP, Sharma J, Babu S. Rizwanulla, Singla a. role of probiotics in health and disease: a review. J Pak Med Assoc. 2013;63(2):253-7.
28. Wescombe PA, Heng NC, Burton JP, Chilcott CN, Tagg JR. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol. 2009;4:819-35. https://doi.org/10.2217/fmb.09.61.
29. Grahn E, Holm SE. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralbl Bakteriol Mikrobiologie Hyg. 1983;256:72-9.
30. Roos K, Grahn E, Lind L, Holm S. Treatment of recurrent streptococcal tonsillitis by recolonization with alpha-streptococci. Eur J Clin Microbiol Infect Dis. 1989;8:318-9.
31. Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol. 1993;25:141-8.
32. Rods K, Holm SE, Grahn-Håkansson E, Lagergren L. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis - a randomized placebo-controlled multicenter study. Scand J Infect Dis. 1996;28:459-62.
33. Worrall G. Acute otitis media. Can Fam Physician. 2007;53:2147-8.
34. Murray RC, Chennupati SK. Chronic streptococcal and non streptococcal pharyngitis. Infect Disord Drug Targets. 2012;12:281-5.
35. Foreman A, Boase S, Psaltis A, Wormald PJ. Role of bacterial and fungal biofilms in chronic rhinosinusitis. Curr Allergy Asthma Rep. 2012;12:127-35.
36. Stressmann FA, Rogers GB, Chan SW, Howarth PH, Harries PG, Bruce KD, et al. Characterization of bacterial community diversity in chronic rhinosinusitis infections using novel culture-independent techniques. Am J Rhinol Allergy. 2011;25:e133ee140. https://doi.org/10.2500/ajra.2011.25.3628.
37. Liu CM, Soldanova K, Nordstrom L, Dwan MG, Moss OL, Contente-Cuomo TL, et al. Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis. Int Forum Allergy Rhinol. 2013;3:775-81. https://doi.org/10.1002/alr.21195.
38. Riley MA, Chavan MA. Bacteriocin: ecology and evolution. Berlin: Springer-Verlag; 2007.
39. Therdtatha P, Tandumrongpong C, Pilasombut K, Matsusaki H, Keawsompong S, Nitisinprasert S. Characterization of antimicrobial substance from lactobacillus salivarius KL-D4 and its application as biopreservative for creamy filling. Springerplus. 2016;5:e1060. https://doi.org/10.1186/s40064-016-2693-4.
40. Khajotia SS, Smart KH, Pilula M, Thompson DM. Concurrent quantification of cellular and extracellular components of biofilms. J Vis Exp. 2013;10:e50639. https://doi.org/10.3791/50639.
41. Davies DG, Marques CN. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol. 2009;191:1393-403. https://doi.org/10.1128/JB.01214-08.
42. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465:346-9. https://doi.org/10.1038/nature09074.
43. Armbruster CE, Hong W, Pang B, Weimer KE, Juneau RA, Turner J, et al. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio. 2014;1:e00102. https://doi.org/10.1128/mBio.00102-10.
44. Dawid S, Roche AM, Weiser JN. The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo. Infect Immun. 2007;75(1):443-51. https://doi.org/10.1128/IAI.01775-05.
45. Yang CC, Konisky J. Colicin V-treated Escherichia coli does not generate membrane potential. J Bacteriol. 1987;158(2):757-9.
46. Pereira CS, Thompson JA, Xavier KB. AI-2-mediated signalling in bacteria. FEMS Microbiol Rev. 2013;37(2):156-81. https://doi.org/10.1111/j.1574-6976.2012.00345.x.
47. Cuadra-Saenz G, Rao DL, Underwood AJ, Belapure SA, Campagna SR, Sun Z, et al. Autoinducer-2 influences interactions amongst pioneer colonizing streptococci in oral biofilms. Microbiology. 2012;158(Pt 7):1783-95. https://doi.org/10.1099/mic.0.057182-0.
48. Rickard AH, Palmer RJ Jr, Blehert DS, Campagna SR, Semmelhack MF, Egland PG, et al. Autoinducer 2: a concentration-dependent signal for mutualistic bacterial biofilm growth. Mol Microbiol. 2006;60(6):1446-56. https://doi.org/10.1111/j.1365-2958.2006.05202.x.
49. Stacy A, McNally L, Darch SE, Brown SP, Whiteley M. The biogeography of polymicrobial infection. Nat Rev Microbiol. 2016;14:93-105. https://doi.org/10.1038/nrmicro.2015.8.